Encoding Higher Level Extensions of Petri Nets in Answer Set Programming

Answering realistic questions about biological systems and pathways similar to the ones used by text books to test understanding of students about biological systems is one of our long term research goals. Often these questions require simulation based reasoning. To answer such questions, we need formalisms to build pathway models, add extensions, simulate, and reason with them. We chose Petri Nets and Answer Set Programming (ASP) as suitable formalisms, since Petri Net models are similar to biological pathway diagrams; and ASP provides easy extension and strong reasoning abilities. We found that certain aspects of biological pathways, such as locations and substance types, cannot be represented succinctly using regular Petri Nets. As a result, we need higher level constructs like colored tokens. In this paper, we show how Petri Nets with colored tokens can be encoded in ASP in an intuitive manner, how additional Petri Net extensions can be added by making small code changes, and how this work furthers our long term research goals. Our approach can be adapted to other domains with similar modeling needs

Representing, reasoning and answering questions about biological pathways - various applications

Biological organisms are composed of numerous interconnected biochemical processes. Diseases occur when normal functionality of these processes is disrupted. Thus, understanding these biochemical processes and their interrelationships is a primary task in biomedical research and a prerequisite for diagnosing diseases, and drug development. Scientists studying these processes have identified various pathways responsible for drug metabolism, and signal transduction, etc. Newer techniques and speed improvements have resulted in deeper knowledge about these pathways, resulting in refined models that tend to be large and complex, making it difficult for a person to remember all aspects of it. Thus, computer models are needed to analyze them. We want to build such a system that allows modeling of biological systems and pathways in such a way that we can answer questions about them. Many existing models focus on structural and/or factoid questions, using surface-level knowledge that does not require understanding the underlying model. We believe these are not the kind of questions that a biologist may ask someone to test their understanding of the biological processes. We want our system to answer the kind of questions a biologist may ask. Such questions appear in early college level text books. Thus the main goal of our thesis is to develop a system that allows us to encode knowledge about biological pathways and answer such questions about them demonstrating understanding of the pathway. To that end, we develop a language that will allow posing such questions and illustrate the utility of our framework with various applications in the biological domain. We use some existing tools with modifications to accomplish our goal. Finally, we apply our system to real world applications by extracting pathway knowledge from text and answering questions related to drug development.Comment: thesi

Knowledge graph-based convolutional network coupled with sentiment analysis towards enhanced drug recommendation

Recommending appropriate drugs to patients based on their history and symptoms is a complex real-world problem. Knowing whether a drug is useful without its consumption by a variety of people followed by proper evaluation is a challenge. Modern-day recommender systems can assist in this provided they receive large data to learn. Public reviews on various drugs are available for knowledge sharing. These reviews assist in recommending the best and most appropriate option to the user. The explicit feedback underpins the entire recommender system. This work develops a novel knowledge graph-based convolutional network for recommending drugs. The knowledge graph is coupled with sentiment analysis extracted from the public reviews on drugs to enhance drug recommendations. For each drug that has been used previously, sentiments have been analyzed to determine which one has the most effective reviews. The knowledge graph effectively captures user-item relatedness by mining its associated attributes. Experiments are performed on public benchmarks and a comparison is made with closely related state-of-the-art works. Based on the obtained results, the current work performs better than the past contributions by achieving up to 98.7% Area Under Curve (AUC) score

Upper Limb Movement Execution Classification using Electroencephalography for Brain Computer Interface

An accurate classification of upper limb movements using electroencephalography (EEG) signals is gaining significant importance in recent years due to the prevalence of brain-computer interfaces. The upper limbs in the human body are crucial since different skeletal segments combine to make a range of motion that helps us in our trivial daily tasks. Decoding EEG-based upper limb movements can be of great help to people with spinal cord injury (SCI) or other neuro-muscular diseases such as amyotrophic lateral sclerosis (ALS), primary lateral sclerosis, and periodic paralysis. This can manifest in a loss of sensory and motor function, which could make a person reliant on others to provide care in day-to-day activities. We can detect and classify upper limb movement activities, whether they be executed or imagined using an EEG-based brain-computer interface (BCI). Toward this goal, we focus our attention on decoding movement execution (ME) of the upper limb in this study. For this purpose, we utilize a publicly available EEG dataset that contains EEG signal recordings from fifteen subjects acquired using a 61-channel EEG device. We propose a method to classify four ME classes for different subjects using spectrograms of the EEG data through pre-trained deep learning (DL) models. Our proposed method of using EEG spectrograms for the classification of ME has shown significant results, where the highest average classification accuracy (for four ME classes) obtained is 87.36%, with one subject achieving the best classification accuracy of 97.03%

Diurnal and Seasonal Mapping of Martian Ices With EMIRS

Condensation and sublimation of ices at the surface of the planet is a key part of both the Martian H$_2$O and CO$_2$ cycles, either from a seasonal or diurnal aspect. While most of the ice is located within the polar caps, surface frost is known to be formed during nighttime down to equatorial latitudes. Here, we use data from the Emirates Mars Infrared Spectrometer (EMIRS) onboard the Emirates Mars Mission (EMM) to monitor the diurnal and seasonal evolution of the ices at the surface of Mars over almost one Martian year. The unique local time coverage provided by the instrument allows us to observe the apparition of equatorial CO$_2$ frost in the second half of the Martian night around the equinoxes, to its sublimation at sunrise

Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients

<p>Abstract</p> <p>Background</p> <p>The aim of this study was to determine glutathione levels and antioxidant enzyme activities in the drug-naive first-episode patients with schizophrenia in comparison with healthy control subjects.</p> <p>Methods</p> <p>It was a case-controlled study carried on twenty-three patients (20 men and 3 women, mean age = 29.3 ± 7.5 years) recruited in their first-episode of schizophrenia and 40 healthy control subjects (36 men and 9 women, mean age = 29.6 ± 6.2 years). In patients, the blood samples were obtained prior to the initiation of neuroleptic treatments. Glutathione levels: total glutathione (GSHt), reduced glutathione (GSHr) and oxidized glutathione (GSSG) and antioxidant enzyme activities: superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase (CAT) were determined by spectrophotometry.</p> <p>Results</p> <p>GSHt and reduced GSHr were significantly lower in patients than in controls, whereas GSSG was significantly higher in patients. GPx activity was significantly higher in patients compared to control subjects. CAT activity was significantly lower in patients, whereas the SOD activity was comparable to that of controls.</p> <p>Conclusion</p> <p>This is a report of decreased plasma levels of GSHt and GSHr, and impaired antioxidant enzyme activities in drug-naive first-episode patients with schizophrenia. The GSH deficit seems to be implicated in psychosis, and may be an important indirect biomarker of oxidative stress in schizophrenia early in the course of illness. Finally, our results provide support for further studies of the possible role of antioxidants as neuroprotective therapeutic strategies for schizophrenia from early stages.</p

EPIdemiology of Surgery-Associated Acute Kidney Injury (EPIS-AKI) : Study protocol for a multicentre, observational trial

More than 300 million surgical procedures are performed each year. Acute kidney injury (AKI) is a common complication after major surgery and is associated with adverse short-term and long-term outcomes. However, there is a large variation in the incidence of reported AKI rates. The establishment of an accurate epidemiology of surgery-associated AKI is important for healthcare policy, quality initiatives, clinical trials, as well as for improving guidelines. The objective of the Epidemiology of Surgery-associated Acute Kidney Injury (EPIS-AKI) trial is to prospectively evaluate the epidemiology of AKI after major surgery using the latest Kidney Disease: Improving Global Outcomes (KDIGO) consensus definition of AKI. EPIS-AKI is an international prospective, observational, multicentre cohort study including 10 000 patients undergoing major surgery who are subsequently admitted to the ICU or a similar high dependency unit. The primary endpoint is the incidence of AKI within 72 hours after surgery according to the KDIGO criteria. Secondary endpoints include use of renal replacement therapy (RRT), mortality during ICU and hospital stay, length of ICU and hospital stay and major adverse kidney events (combined endpoint consisting of persistent renal dysfunction, RRT and mortality) at day 90. Further, we will evaluate preoperative and intraoperative risk factors affecting the incidence of postoperative AKI. In an add-on analysis, we will assess urinary biomarkers for early detection of AKI. EPIS-AKI has been approved by the leading Ethics Committee of the Medical Council North Rhine-Westphalia, of the Westphalian Wilhelms-University Münster and the corresponding Ethics Committee at each participating site. Results will be disseminated widely and published in peer-reviewed journals, presented at conferences and used to design further AKI-related trials. Trial registration number NCT04165369

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

As mortality rates decline, life expectancy increases, and populations age, non-fatal outcomes of diseases and injuries are becoming a larger component of the global burden of disease. The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of prevalence, incidence, and years lived with disability (YLDs) for 328 causes in 195 countries and territories from 1990 to 2016